Subscribe
Subscribe
Home Authors Posts by Peter Pitts

Peter Pitts

The Food and Drug Administration seal is seen before the Health and Human Services Secretary Robert F. Kennedy Jr. news conference on the FDA's intent to phase out the use of petroleum-based synthetic dyes in the nation's food supply at the Hubert Humphrey Building Auditorium in Washington, Tuesday, April 22, 2025. (AP Photo/Jose Luis Magana)
Op-Eds

The FDA is moving faster on psychedelics — now Washington must do more

Peter Pitts -
0
Pundits and policymakers need a dose of facts — not the alternative kind — to cure their soundbite-itis.
Beltway Confidential

Fake news mustn’t drive the healthcare debate

Peter Pitts -
0
Allowing the feds to negotiate drug prices under Part D likely would have a negative effect on the program. (AP Photo/Rich Pedroncelli)
Healthcare

President Trump misunderstands what government drug price negotiations entail

Peter Pitts -
0
The economics of American healthcare are dictated by the Golden Rule:
Economy

Cheaper drugs can also mean less choice without savings for patients

Peter Pitts -
0
New drug shortages declined in 2012 for the first time in a number of years and 2013 data indicated a similar downward trend. (Photo: Thinkstock)
Healthcare

FDA’s plan to ease drug shortages needs work

Peter Pitts -
0
Morning sickness is a common problem for pregnant women. (Thinkstock)
Healthcare

Obamacare forces insurers to cover birth control drugs but not those for morning sickness

Peter Pitts -
0
Studies show not taking medications as prescribed leads to poorer health, more frequent hospitalization, a higher risk of death and as much as $290 billion annually in increased medical costs. But as any health care provider will tell you, the fact that actually taking a medication as prescribed is in a patient’s best interest does not lead to a patient doing what is in his best interest. (Photo: Thinkstock)
Op-Eds

Grandstanding AGs sue to stop drugmaker’s work to insure patients take medicine properly

Peter Pitts -
0
When it comes to biosimilars, we need to be extremely thoughtful about how we set policy relating to these promising medicines and strike a balance that promotes health and safety, rather than forcing a binary response that is driven by profits rather than patients. (Photo: Thinkstock)
Op-Eds

FDA must decide if a biosimilar rose by any other name is still a rose

Peter Pitts -
0
If the federal bureaucracy continues to stall on producing the N7N9 vaccine, HHS could face a catastrophe that would make the healthcare.gov storm seem like a light spring shower. (Photo: Thinkstock)
Op-Eds

Here comes the next big healthcare disaster, courtesy of HHS

Peter Pitts -
0
Obama’s fiscal cliff drug ‘reform’ idea will backfire
Op-Eds

Obama’s fiscal cliff drug ‘reform’ idea will backfire

Peter Pitts -
0
12Page 1 of 2
Do Not Sell or Share My Personal Information

NEWS

POLICY

COMMENTARY

RESTORING AMERICA

  • © Copyright 2026. Washington Examiner. All Rights Reserved.